Clinical trials with multiple outcomes: A statistical perspective on their design, analysis, and interpretation

Controlled Clinical Trials

Volumn 18, Issue 6, 1997, Pages 530-545

  Pocock, Stuart J ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Clinical trials; Multiple outcome measures

Indexed keywords

ACETYLSALICYLIC ACID; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; PLACEBO; SIMVASTATIN; SULFINPYRAZONE;

CLINICAL TRIAL; CONFERENCE PAPER; DEATH; HEART DEATH; HEART INFARCTION; HUMAN; STATISTICAL ANALYSIS; SUDDEN DEATH; TREATMENT OUTCOME;

CLINICAL TRIALS; CLUSTER ANALYSIS; CORONARY DISEASE; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); RESEARCH DESIGN;

EID: 0030723636     PISSN: 01972456     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-2456(97)00008-1     Document Type: Conference Paper

References (15)

1. Cook RJ, Farewell VT. Multiplicity considerations in the design and analysis of clincial trials. Stat in Soc (JRSSA) 1996;159:93-110.
2. Pocock SJ, Hughes MD, Lee RJ. Statistical problems in the reporting of clinical trials. N Engl J Med 1987;317:426-432.
3. Anturane Reinfarction Trial Research Group. Sulfinpyrazone in the prevention of sudden death after myocardial infarction. N Engl J Med 1980;302:250-256.
4. Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease. Lancet 1994;344:1383-1389.
5. Pocock SJ, Geller NL, Tsiatis AA. The analysis of multiple endpoints in clinical trials. Biometrics 1987;43:487-498.
6. Simes RJ. An improved Bonferroni procedure for multiple tests of significance. Biometrika 1986;73:751-754.
7. Hochberg Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrika 1988;75:800-802.
8. OBrien PC. Procedures for comparing samples with multiple endpoints. Biometrics 1984;40:1079-1087.
9. Tang D-I, Gnecco C, Geller NL. An approximate likelihood ratio for a normal mean vector with non-negative components with application to clinical trials. Biometrika 1989;76:577-583.
10. MAAS investigators. Effect of simvastatin on coronary atheroma: The multi-centre anti-atheroma study. Lancet 1994;633-638.
11. Steering Committee of hte Physicians Health Study Research Group. Final report on the aspirin component of the ongoing physicians health study. N Engl J Med 1989;321:129-135.
12. RITA trial participants. Coronary angioplasty versus coronary artery bypass surgery: the randomised intervention treatment of angina (RITA) trial. Lancet 1993;341: 573-580.
13. Pocock SJ, Henderson RA, Rickards AF, et al. A meta-analysis of the randomized trials comparing coronary angioplasty with bypass surgery. Lancet 1995;346: 1184-1189.
14. Pocock SJ, Henderson RA, Seed P, et al. Quality of life, employment status and anginal symptoms after coronary angioplasty or bypass surgery: three year follow-up in the RITA trial. Circulation 1996;
15. Dutch Chronic Non-Specific Lung Disease Study Group. A comparison of bronchodilator therapy with and without inhaled corticosteroid therapy for obstructive airways disease. N Engl J Med 1992;327:1413-1419.